The authors discuss the use of per- and polyfluoroalkyl substances (PFAS) immunotoxicity data in regulatory and clinical decision-making contexts and question whether recent efforts adequately account for PFAS immunotoxicity in public health decision-making.
[Current Environmental Health Reports]
